Bioabsorbable implantable long‑acting drug‑delivery platform that provides multi‑month medication release to improve adherence in chronic conditions. Lead product: long‑acting naltrexone implant for opioid use disorder; pipeline includes buprenorphine implants and exploratory GLP‑1 implants for metabolic/obesity care.